These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2967374)
21. Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonists. Kelly PA; Davis CJ; Goodwin GM Neuroscience; 1988 Jun; 25(3):907-15. PubMed ID: 2970017 [TBL] [Abstract][Full Text] [Related]
22. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761 [TBL] [Abstract][Full Text] [Related]
23. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT). Mellin C; Liu Y; Hacksell U; Björk L; Andén NE Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167 [No Abstract] [Full Text] [Related]
24. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors. Shippenberg TS Neurosci Lett; 1991 Jan; 121(1-2):136-8. PubMed ID: 1826942 [TBL] [Abstract][Full Text] [Related]
25. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785 [TBL] [Abstract][Full Text] [Related]
27. The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine. Berge OG; Fasmer OB; Ogren SO; Hole K Neurosci Lett; 1985 Feb; 54(1):71-5. PubMed ID: 3156286 [TBL] [Abstract][Full Text] [Related]
28. Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection. Perry KW; Fuller RW Biochem Pharmacol; 1989 Oct; 38(19):3169-73. PubMed ID: 2530985 [TBL] [Abstract][Full Text] [Related]
29. [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system]. Ponchant M; Beaucourt JP; Vanhove A; Daval G; Vergé D; Hamon M; Gozlan H C R Acad Sci III; 1988; 306(4):147-52. PubMed ID: 2965963 [TBL] [Abstract][Full Text] [Related]
30. Resolution of 5,6-dihydroxy-2-(N,N-di-n-propylamino)tetralin in relation to the structural and stereochemical requirements for centrally acting dopamine agonists. Grol CJ; Jansen LJ; Rollema H J Med Chem; 1985 May; 28(5):679-83. PubMed ID: 4039369 [TBL] [Abstract][Full Text] [Related]
31. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo. Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131 [TBL] [Abstract][Full Text] [Related]
32. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Marcinkiewicz M; Vergé D; Gozlan H; Pichat L; Hamon M Brain Res; 1984 Jan; 291(1):159-63. PubMed ID: 6230136 [TBL] [Abstract][Full Text] [Related]
33. Effect of 8-hydroxy-2-(di-n-propylamino)-tetralin on the tryptophan-induced increase in 5-hydroxytryptophan accumulation in rat brain. Fernstrom MH; Massoudi MS; Fernstrom JD Life Sci; 1990; 47(4):283-9. PubMed ID: 2143798 [TBL] [Abstract][Full Text] [Related]
34. Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats. Fuller RW; Snoddy HD Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):409-12. PubMed ID: 2449711 [TBL] [Abstract][Full Text] [Related]
35. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Cervo L; Grignaschi G; Samanin R Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608 [TBL] [Abstract][Full Text] [Related]
36. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Tricklebank MD; Forler C; Fozard JR Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568 [TBL] [Abstract][Full Text] [Related]
37. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002 [TBL] [Abstract][Full Text] [Related]
38. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites. Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252 [TBL] [Abstract][Full Text] [Related]
39. Failure to antagonize the 8-hydroxy-2-di-n-propylamino)tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists. Ahlenius S; Larsson K Eur J Pharmacol; 1984 Apr; 99(4):279-86. PubMed ID: 6234182 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy. Löscher W; Czuczwar SJ Neurosci Lett; 1985 Sep; 60(2):201-6. PubMed ID: 2932661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]